Garmin announces the ECG App for the Venu® 2 Plus smartwatch

Garmin^® International announced the ECG App¹, an FDA-cleared app for the Venu^® 2 Plus smartwatch that allows users to record their heart rhythm and check for signs of atrial fibrillation (AFib) anytime, anywhere. Customers can use the ECG App to record a 30-second ECG and view their heart rhythm results immediately on the watch or, optionally, later in the Garmin Connect^™ smartphone app.

When customers take an ECG, the ECG App uses sensors on the Venu 2 Plus to record the electrical signals that control how their heart beats. The ECG App then analyzes that recording to detect signs of AFib. Additionally, users have the option to sync their ECG App results to Garmin Connect. Through the Garmin Connect app, customers can view their history of ECG App results and create reports that can be shared with a health care provider.

The ECG App is available now on the Venu 2 Plus for customers in the United States and requires the latest version of the Garmin Connect app before use. Garmin intends to continue to expand its portfolio of products supporting the ECG App and launch it in new regions in-line with necessary regulatory approval. For more information on the ECG App and how to set it up, visit Garmin.com/ECG.

^{1The ECG app is available on the Venu 2 Plus smartwatch (firmware version 11.21) with the Garmin Connect smartphone app (version 4.62). The ECG app is not intended for use by people under 22 years old. With the ECG app, the Venu 2 Plus smartwatch is capable of generating an ECG similar to a single-lead electrocardiogram.}